Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Angeliki Malliri
AstraZeneca, UK
Carla Martins
Charité, Berlin, Germany
Christine Sers
Frederick National Laboratory for Cancer Research, USA
Dhirendra Simanshu
IRB, Barcelona, Spain
Direna Alonso
IBMCC-CIC, Salamanca, Spain
Esther Castellano
Department of Oncology - University of Turin - San Luigi hospital , Orbassano (TO) - Italy
Francesco Passiglia
University of California, San Francisco, USA
Frank McCormick
Max Perutz Labs, University of Vienna, Vienna BioCenter, Vienna, Austria
Georg Vucak
Revolution Medicince, USA
Jan Smith
VIB-VUB Center for Structural Biology, VIB & Vrije Universiteit Brussel, Brussels, Belgium
Jan Steyaert
Beaumont RCSI Cancer Centre, Dublin, Ireland
Jarushka Naidoo
Peter MacCallum Cancer Centre, Melbourne, Australia
Jayesh Desai
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Jia Luo
Francis Crick Institute, London, UK
Julian Downward
Brigham & Women's Hospital, Harvard Medical School, Boston, USA
Karen Cichowski
University of California, San Francisco, USA
Kevan Shokat
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Kevin Haigis
University of Dundee, Dundee, UK
Kirsten McAulay
John Hopkins University School of Medicine, Baltimore, USA
Laura Wood
Center for Cancer Research, Medical University of Vienna
Maria Sibilia
Boehringer Ingelheim, Germany
Mark Pearson
Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
Martin McMahon
Cancer Research UK, Cambridge, UK
Masashi Narita
BridgeBio Oncology Therapeutics
Pedro Beltrán
Memorial Sloan Kettering Cancer Center, New York, USA
Piro Lito
Institut Gustave Roussy, Villejuif, France
Sophie de Carné
Memorial Sloan Kettering Cancer Center, New York, USA